Clinical Trials on Advanced Solid Malignancies
Total 10697 results
-
Athenex, Inc.CompletedAdvance MalignanciesUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Non-hematologic MalignanciesUnited States, Canada
-
SCRI Development Innovations, LLCNovartisCompletedAdvanced Malignancies | Refractory MalignancyUnited States
-
PfizerActive, not recruitingOvarian Cancer | NSCLC | Solid Tumors | Urothelial Cancer | Advanced MalignanciesHungary, Spain, United States, Canada, Taiwan, Japan, Serbia, Italy, New Zealand, Australia, Mexico, Russian Federation, United Kingdom, France, Korea, Republic of, Belgium, Poland, Denmark, Israel
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid Tumors | Hematologic MalignanciesUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid Tumors, Neoplasms, Advanced SolidHungary
-
AstraZenecaCompletedAdvanced Solid Tumor | Advanced Solid MalignancyJapan
-
German Cancer Research CenterRecruiting
-
Regeneron PharmaceuticalsTerminatedAdvanced PD-L1 Positive MalignanciesUnited States
-
Regeneron PharmaceuticalsSanofiCompletedAdvanced Cancer | Advanced MalignanciesUnited States, Spain, Australia
-
University of California, San FranciscoCompletedIntegrative Palliative Care/Psycho-Oncology Telehealth Intervention in Patients With Advanced CancerAdvanced Malignant Solid Neoplasm | Locally Advanced Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
AstraZenecaRecruitingAdvanced Solid MalignanciesUnited States, Korea, Republic of, Spain, Australia, Sweden, Germany, United Kingdom
-
Institut Cancerologie de l'OuestRecruitingRelapsed Hematologic Malignancy | Advanced or Metastatic Solid TumorFrance
-
Calithera Biosciences, IncCompletedAdvanced Solid Tumor and Lymphoma MalignanciesUnited States, Spain, Italy, United Kingdom
-
AmgenTerminatedAdvanced Non-Central Nervous System (CNS) MalignanciesUnited States
-
AstraZenecaCompletedAdvanced Solid Malignancies | Malignant LymphomaUnited Kingdom, Japan
-
Agenus Inc.CompletedAdvanced Solid Cancers | Advanced Solid Cancers Refractory to PD-1United States
-
AmgenCompletedCancer | Advanced Solid Tumors | Solid Tumors | Tumors | Advanced MalignancyUnited States, Australia
-
NantCell, Inc.CompletedQUILT-2.016: Study of AMG 479 With Biologics or Chemotherapy for Subjects With Advanced Solid TumorsCancer | Advanced Solid Tumors | Solid Tumors | Tumors | Advanced Malignancy
-
Ospedale Santa Croce-Carle CuneoUnknownAdvanced Haematological Malignancies | High Risk Haematological MalignanciesItaly
-
BeiGeneRecruitingSolid Tumor | Advanced Solid TumorUnited States, New Zealand, Australia, China
-
Hoffmann-La RocheCompletedSolid Tumors, Advanced Solid TumorsUnited States
-
Esperance Pharmaceuticals IncCompletedAdvanced Solid Tumors | Solid TumorsUnited States
-
Incyte CorporationRecruitingA Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid TumorsAdvanced Solid Tumors | Solid Tumors | Metastatic Solid TumorsUnited States, Spain, United Kingdom, France, Italy, Denmark, Switzerland
-
German Cancer Research CenterGerman Consortium for Translational Cancer ResearchCompletedMetastatic and Locally Advanced NRG1-rearranged MalignanciesGermany
-
InnoPharmax Inc.CompletedAdvanced Solid Malignancies | Malignant LymphomasTaiwan
-
AstraZenecaTerminatedSolid MalignanciesUnited States
-
Tel-Aviv Sourasky Medical CenterMeir Medical Center; Max Planck Institute for Infection BiologyUnknownPediatric Solid Malignancies | Pediatric Hematological MalignanciesIsrael
-
GI Innovation, Inc.RecruitingAdvanced Solid Tumor | Metastatic Solid TumorKorea, Republic of, United States
-
Aadi Bioscience, Inc.RecruitingAdvanced Solid Tumor | Tumor | Tumor, SolidUnited States
-
Genentech, Inc.RecruitingAdvanced Solid Tumors | Metastatic Solid TumorsCanada, Korea, Republic of, United States, Brazil, Australia, Argentina, Spain, New Zealand, Poland
-
Xenthera, Inc.Not yet recruitingAdvanced Solid Tumor | Metastatic Solid Tumor
-
Regeneron PharmaceuticalsRecruitingAdvanced Solid Tumor | Metastatic Solid TumorNetherlands
-
Philogen S.p.A.RecruitingAdvanced Solid Tumor | Metastatic Solid TumorItaly, Germany, Switzerland
-
Novartis PharmaceuticalsTerminatedCancer | Solid Tumor | Advanced Solid TumorJapan
-
Impact Therapeutics, Inc.RecruitingSolid Tumor | Advanced Solid TumorChina, Taiwan, United States, Australia
-
Ningbo Cancer HospitalUnknownAdvanced Malignancies | PD-1 Antibody | CAR-T CellsChina
-
Quanta TherapeuticsRecruiting
-
Xizang Haisco Pharmaceutical Co., LtdRecruiting
-
Tianjin ConjuStar Biologics Co., Ltd.Recruiting
-
China-Japan Friendship HospitalRecruitingAdvanced Solid TumorChina
-
AkesoNot yet recruiting
-
Sichuan Honghe Biotechnology Co., Ltd.Recruiting
-
SelecxineRecruitingAdvanced Solid TumorUnited States, Australia, Korea, Republic of
-
Bio-Thera SolutionsRecruitingAdvanced Solid TumorsChina
-
Betta Pharmaceuticals Co., Ltd.RecruitingAdvanced Solid TumorChina
-
Jiangsu Aosaikang Pharmaceutical Co., Ltd.RecruitingAdvanced Solid TumorChina
-
Nanjing Leads Biolabs Co.,LtdRecruiting
-
Chang Gung Memorial HospitalRecruiting
-
Sunnybrook Health Sciences CentreUniversity of Toronto; Princess Margaret Hospital, CanadaRecruiting